DMSO-PDT of BCC - A 6 Year Follow Up

This study has been completed.

Sponsored by:	Norwegian University of Science and Technology
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00218829

Purpose

The purpose of this study is to registrate long time clinical and histological treatment response of BCC lesions treated with one or two procedures of DMSO-PDT.

Condition
Carcinoma, Basal Cell

Drug Information available for: Dimethyl sulfoxide

U.S. FDA Resources

Study Type:	Observational
Study Design:	Longitudinal, Convenience Sample, Prospective Study
Official Title:	Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.

Further study details as provided by Norwegian University of Science and Technology:

Estimated Enrollment:	48
Study Start Date:	September 1997

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

histological verified bcc.
one or two PDT treatments with treatment interval no longer than two weeks.
lesion complete response three months after therapy.

Exclusion Criteria:

pregnant.
Gorlin's syndrome.
morpheaform or pigmented bcc.
histology older than one year.
tumour infiltration more than four mm.
previous PDT treated lesions.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218829

Sponsors and Collaborators

Norwegian University of Science and Technology

Investigators

Principal Investigator:

Eidi Christensen, MD

St. Olav University Hospital, Trondheim

More Information

Study ID Numbers:	EC-002
Study First Received:	September 20, 2005
Last Updated:	May 16, 2006
ClinicalTrials.gov Identifier:	NCT00218829
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:

Photodynamic treatment
Basal cell carcinoma
DMSO

Study placed in the following topic categories:

Dimethyl Sulfoxide
Carcinoma, Basal Cell
Neoplasms, Glandular and Epithelial
Carcinoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type
Neoplasms, Basal Cell

ClinicalTrials.gov processed this record on February 09, 2009